Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Regiane S. S. M. Alencar"'
Autor:
Aline Lopes Chagas, Regiane S. S. M. Alencar, Paulo M. Hoff, Fabio Payao, Karina Gondim Moutinho da Conceição Vasconcelos, Heloisa de Andrade Carvalho, Claudia Megumi Tani, Manoel de Souza Rocha, Flair José Carrilho, Andre Tsin Chih Chen
Publikováno v:
Rep Pract Oncol Radiother
BACKGROUND: The aim of the study was to evaluate the feasibility and safety of stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma in Brazil. SBRT is an evolving treatment in HCC patients not candidates to other local
Autor:
Regiane S. S. M. Alencar, Aline Lopes Chagas, Natally Horvat, Edson Abdala, Claudia Maccali, Lisa Rodrigues da Cunha Saud, Flair José Carrilho, Paulo Victor Alves Pinto, Claudia Megumi Tani
Publikováno v:
Eur J Gastroenterol Hepatol
INTRODUCTION AND OBJECTIVES: Hepatocellular carcinoma (HCC) is the 6(th) cause of cancer and hepatitis C (HCV) and B (HBV) viruses are the most frequent risk factors for HCC. Patients co-infected with HCV or HBV and human immunodeficiency virus (HIV)
Autor:
Wellington Andraus, Francisco Cesar Carnevale, Lisa Rodrigues da Cunha Saud, Aline Lopes Chagas, Claudia Megumi Tani, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman, Fabricio Ferreira Coelho, Regiane S. S. M. Alencar, Marcos Roberto de Menezes, Airton Mota Moreira, Flair José Carrilho, Lucas Fiore, Leonardo Gomes da Fonseca, Edson Abadala
Publikováno v:
Clinics; v. 75 (2020); e2192
Clinics; Vol. 75 (2020); e2192
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Volume: 75, Article number: e2192, Published: 27 NOV 2020
Clinics; Vol. 75 (2020); e2192
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Volume: 75, Article number: e2192, Published: 27 NOV 2020
More than 18 million people in 188 countries have been diagnosed as having coronavirus disease (COVID-19), and COVID-19 has been responsible for more than 600,000 deaths worldwide. Brazil is now the second most affected country globally. Faced with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea89d750383541913591e8149dd94abb
https://www.revistas.usp.br/clinics/article/view/192404
https://www.revistas.usp.br/clinics/article/view/192404
Autor:
Aline Lopes Chagas, Denise Cerqueira Paranaguá-Vezozzo, Leonardo Gomes da Fonseca, Regiane S. S. M. Alencar, Flair José Carrilho
Publikováno v:
Seminars in liver disease. 40(2)
Over 38,000 cases of hepatocellular carcinoma (HCC) are estimated to occur in Latin America annually. The region is characterized by sociocultural heterogeneity and economic disparities, which impose barriers in addressing this major health issue. A
Autor:
Venancio Avancini Ferreira Alves, Luciana Kikuchi, Marcio A. Diniz, José Tadeu Stefano, Aline Lopes Chagas, Claudia Megumi Tani, Denise P. Vezozzo, Gilmar R. Santos, Mário Reis Álvares-da-Silva, Claudia P. Oliveira, Priscila Brizolla de Campos, Regiane S. S. M. Alencar, Flair José Carrilho, Vlad Ratziu
Publikováno v:
American Journal of Clinical Oncology. 39:428-432
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) has emerged as an important cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). The Barcelona Clinic Liver Cancer (BCLC) system is the preferred staging system to ev
Autor:
Luciana Kikuchi, Paulo M. Hoff, Claudia Megumi Tani, Aline Lopes Chagas, Tulio Eduardo Flesch Pfiffer, Regiane S. S. M. Alencar, Cinira Cintra Camargo, Flair José Carrilho
Publikováno v:
Journal of Cancer Therapy. :275-284
Introduction: Sorafenib is an orally active multikinase inhibitor approved for the treatment of advanced hepatocellular carcinoma (HCC) and is the only systemic treatment associated with a survival benefit in advanced stage. The aims of this study we
Autor:
Luciana Kikuchi, Claudia Megumi Tani, Aline Lopes Chagas, Regiane S. S. M. Alencar, Francisco Cesar Carnevale, Marcio A. Diniz, Natália Sousa Freitas Queiroz, Airton Mota Moreira, Aline Cristine Barbosa Santos, Regis Otaviano Franca Bezerra, Luiz Augusto Carneiro D'Albuquerque, Manoel de Souza Rocha, Flair José Carrilho
Publikováno v:
Journal of Cancer Therapy. :1115-1123
Introduction: Transarterial chemoembolization (TACE) reduces tumor growth and increases survival in patients with hepatocellular carcinoma (HCC). Drug-eluting beads (DEB) deliver slow-release chemotherapy and reduce systemic toxicity during TACE. Thi
Autor:
Aline Lopes Chagas, Paulo Herman, Vincenzo Pugliese, Luciana Kikuchi, Flair José Carrilho, Marcio A. Diniz, Claudia Megumi Tani, Regiane S. S. M. Alencar, Luiz Augusto Carneiro D´Albuquerque, Venancio Avancini Ferreira Alves, Manoel de Souza Rocha
Publikováno v:
Clinics, Volume: 70, Issue: 3, Pages: 207-213, Published: MAR 2015
Clinics; v. 70 n. 3 (2015); 207-213
Clinics; Vol. 70 Núm. 3 (2015); 207-213
Clinics; Vol. 70 No. 3 (2015); 207-213
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 70, Iss 3, Pp 207-213 (2015)
Clinics; v. 70 n. 3 (2015); 207-213
Clinics; Vol. 70 Núm. 3 (2015); 207-213
Clinics; Vol. 70 No. 3 (2015); 207-213
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 70, Iss 3, Pp 207-213 (2015)
OBJECTIVES: Fibrolamellar hepatocellular carcinoma is a rare primary malignant liver tumor that differs from conventional hepatocellular carcinoma in several aspects. The aim of this study was to describe the clinical, surgical and histopathological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ecc599e6f9697bd4ed624386199688
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000300207&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000300207&lng=en&tlng=en
Autor:
Aline Lopes Chagas, Marcio A. Diniz, Claudia Megumi Tani, Regiane S. S. M. Alencar, Luiz Augusto Carneiro D'Albuquerque, Venâncio Avancini Ferreira Alves, Marcos Roberto de Menezes, Luciana Kikuchi, Flair José Carrilho
Publikováno v:
World journal of gastroenterology. 20(6)
To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular carcinoma (HCC) and identify survival- and recurrence-related factors.Consecutive patients diagnosed with early HCC by computed tomography (CT) or magnetic resonan
Autor:
Fernanda Branco, Flair José Carrilho, Fernanda Volt, Angelo Alves de Mattos, Regiane S. S. M. Alencar, Aline Lopes Chagas, Andressa Dode, Luciana Kikuchi, Giovana D.P. Sartori, Paulo M. Hoff, Tulio Eduardo Flesch Pfiffer, Claudia Megumi Tani
Publikováno v:
Annals of Hepatology, Vol 16, Iss 2, Pp 247-254 (2017)
Background and aim Transarterial chemoembolization (TACE) or sorafenib is recommended for hepatocellular carcinoma BCLC stages B and C respectively. We studied the role of combination of TACE and sorafenib in BCLC stages B/C. Material and methods We